Ionis Pharmaceuticals, Inc. (IONS)
55.17
-0.48
(-0.86%)
USD |
NASDAQ |
Sep 11, 13:46
Ionis Pharmaceuticals Gross Profit (TTM) : 835.84M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 835.84M |
| March 31, 2026 | 1.023B |
| December 31, 2025 | 912.39M |
| September 30, 2025 | 939.02M |
| June 30, 2025 | 914.77M |
| March 31, 2025 | 685.24M |
| December 31, 2024 | 672.18M |
| September 30, 2024 | 770.84M |
| June 30, 2024 | 780.02M |
| March 31, 2024 | 744.69M |
| December 31, 2023 | 756.57M |
| September 30, 2023 | 581.16M |
| June 30, 2023 | 597.89M |
| March 31, 2023 | 541.66M |
| December 31, 2022 | 550.94M |
| September 30, 2022 | 842.99M |
| June 30, 2022 | 815.14M |
| March 31, 2022 | 808.96M |
| December 31, 2021 | 780.28M |
| September 30, 2021 | 629.69M |
| June 30, 2021 | 656.93M |
| March 31, 2021 | 677.64M |
| December 31, 2020 | 700.18M |
| September 30, 2020 | 906.34M |
| June 30, 2020 | 917.04M |
| Date | Value |
|---|---|
| March 31, 2020 | 937.34M |
| December 31, 2019 | 1.103B |
| September 30, 2019 | 802.48M |
| June 30, 2019 | 639.24M |
| March 31, 2019 | 480.44M |
| December 31, 2018 | 187.81M |
| September 30, 2018 | 171.30M |
| June 30, 2018 | 171.30M |
| March 31, 2018 | 171.30M |
| December 31, 2017 | 171.30M |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 3.827B |
| Biogen, Inc. | 6.211B |
| BridgeBio Pharma, Inc. | 671.14M |
| Vertex Pharmaceuticals, Inc. | 10.94B |
| Arrowhead Pharmaceuticals, Inc. | 643.69M |